RecruitingNCT04214119

EsophaCap for the Detection of Early Esophageal Carcinoma

Sponsor

Johns Hopkins University

Enrollment

2,500 participants

Start Date

Jan 12, 2016

Study Type

OBSERVATIONAL

Conditions

Esophageal Cancer Gastric Cancer Barrett Esophagus

Summary

This study is to identify potential biomarkers for the early detection of Barrett's Esophagus, esophageal carcinoma (both adenocarcinoma and squamous cell carcinoma), and gastric cancer via sponge cytology.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is testing a swallowable capsule device (EsophaCap) that collects cells from the esophagus without needing a full endoscopy, to see if it can detect early esophageal cancer or precancerous changes as effectively as standard procedures. **You may be eligible if...** - You are 18 or older - You are already scheduled for an upper endoscopy (EGD) at Johns Hopkins Hospital - You are able to swallow a capsule **You may NOT be eligible if...** - You have cancer in areas outside the esophagus (head, neck, or stomach) - You have had your esophagus surgically removed (esophagectomy) - You have had radiation to the chest - You have an esophageal stent - You have esophageal narrowing (strictures) that would prevent the capsule from passing Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.